CellPro

Suzhou CellPro Biotechnology (CellProBio) is a leading Chinese life sciences company specializing in the research, development, and large-scale manufacturing of high-end laboratory consumables and diagnostic products. Founded in 2018 and headquartered in Suzhou, the company has rapidly expanded its portfolio to include over 900 SKUs, ranging from pipette tips and cell culture plates to specialized diagnostic kits for assisted reproductive technology (ART). In 2021, a 51% stake in the company was acquired by Suzhou Basecare Medical, a prominent player in the genetic testing market for reproduction. CellPro operates advanced automated production lines and serves a global distribution network covering more than 50 countries, positioning itself as a key supplier for molecular diagnostics, immunotherapy, and biopharmaceutical research.